ALNOV:EPA
Novacyt SA
€ ०.४२
arrow_downward
-०.४७%(-०.००२०) 1D
नोभेम्बर १०, १३:०२:४९ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
€ ०.४२
High
€ ०.४२
Low
€ ०.४२
Mkt. cap
३.०५ करोड
Avg. vol.
१.७३ लाख
Volume
२२.६४ हजार
52-wk high
€ १.०४
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२२८
Open
€ ०.४२
High
€ ०.४२
Low
€ ०.४२
Mkt. cap
३.०५ करोड
Avg. vol.
१.७३ लाख
Volume
२२.६४ हजार
52-wk high
€ १.०४
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२२८
News stories
From web sources and news partners
CNBC
·
५४ मिनेट पहिले
Anthropic sets price range of $70 to $78 in upcoming IPO as AI lab marches towards Nasdaq
The Motley Fool
·
२८ मिनेट पहिले
Nasdaq-100 Correction: 2 Proven Winners That Can Buck Historic Volatility
24/7 Wall St.
·
१८ मिनेट पहिले
The Nasdaq-100 Just Had Its Best Day Since March Without Nvidia’s Help
Bloomberg.com
·
१ घण्टा पहिले
Asian Stocks to Rally on US Tech Surge, Oil Slump: Markets Wrap
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees२२८
Founded२००६ जुलाई ३
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com